In the context of CARs, several groups have generated fibroblast activation protein (FAP)-redirected CAR T cells to erase FAP-expressing CAFs, resulting in a reduction of ECM molecules and tumour growth, also in a syngeneic murine pancreatic cancer model [34,35,36]. The gene discussed is FAP; the disease is neoplasm.